The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Direct Agglutination Test Market Research Report 2025
Synopsis
The Direct Agglutination Test (DAT) is a diagnostic test used in immunology to detect antibodies or antigens in a patient's sample, typically blood or other body fluids. It is commonly used to diagnose and monitor infectious diseases caused by certain pathogens, especially those that induce antibody production.
Global Direct Agglutination Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct Agglutination Test market research.
Key companies engaged in the Direct Agglutination Test industry include Atlas Medical GmbH, Thermo Fisher Scientific, Bio-Rad, HiMedia, Pro Lab, Arlington Scientific, Hardy Diagnostics, Liofilchem S.r.l and Biotec, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Direct Agglutination Test were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Direct Agglutination Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Direct Agglutination Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Atlas Medical GmbH
Thermo Fisher Scientific
Bio-Rad
HiMedia
Pro Lab
Arlington Scientific
Hardy Diagnostics
Liofilchem S.r.l
Biotec
Segment by Type
Blood
Urine
Escherichia Coli
Others
Segment by Application
Clinics
Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct Agglutination Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The Direct Agglutination Test (DAT) is a diagnostic test used in immunology to detect antibodies or antigens in a patient's sample, typically blood or other body fluids. It is commonly used to diagnose and monitor infectious diseases caused by certain pathogens, especially those that induce antibody production.
Global Direct Agglutination Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct Agglutination Test market research.
Key companies engaged in the Direct Agglutination Test industry include Atlas Medical GmbH, Thermo Fisher Scientific, Bio-Rad, HiMedia, Pro Lab, Arlington Scientific, Hardy Diagnostics, Liofilchem S.r.l and Biotec, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Direct Agglutination Test were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Direct Agglutination Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Direct Agglutination Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Atlas Medical GmbH
Thermo Fisher Scientific
Bio-Rad
HiMedia
Pro Lab
Arlington Scientific
Hardy Diagnostics
Liofilchem S.r.l
Biotec
Segment by Type
Blood
Urine
Escherichia Coli
Others
Segment by Application
Clinics
Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct Agglutination Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Direct Agglutination Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood
1.2.3 Urine
1.2.4 Escherichia Coli
1.2.5 Others
1.3 Market by Application
1.3.1 Global Direct Agglutination Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospital
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Direct Agglutination Test Market Perspective (2018-2029)
2.2 Direct Agglutination Test Growth Trends by Region
2.2.1 Global Direct Agglutination Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Direct Agglutination Test Historic Market Size by Region (2018-2023)
2.2.3 Direct Agglutination Test Forecasted Market Size by Region (2024-2029)
2.3 Direct Agglutination Test Market Dynamics
2.3.1 Direct Agglutination Test Industry Trends
2.3.2 Direct Agglutination Test Market Drivers
2.3.3 Direct Agglutination Test Market Challenges
2.3.4 Direct Agglutination Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Direct Agglutination Test Players by Revenue
3.1.1 Global Top Direct Agglutination Test Players by Revenue (2018-2023)
3.1.2 Global Direct Agglutination Test Revenue Market Share by Players (2018-2023)
3.2 Global Direct Agglutination Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Direct Agglutination Test Revenue
3.4 Global Direct Agglutination Test Market Concentration Ratio
3.4.1 Global Direct Agglutination Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Direct Agglutination Test Revenue in 2022
3.5 Direct Agglutination Test Key Players Head office and Area Served
3.6 Key Players Direct Agglutination Test Product Solution and Service
3.7 Date of Enter into Direct Agglutination Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Direct Agglutination Test Breakdown Data by Type
4.1 Global Direct Agglutination Test Historic Market Size by Type (2018-2023)
4.2 Global Direct Agglutination Test Forecasted Market Size by Type (2024-2029)
5 Direct Agglutination Test Breakdown Data by Application
5.1 Global Direct Agglutination Test Historic Market Size by Application (2018-2023)
5.2 Global Direct Agglutination Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Direct Agglutination Test Market Size (2018-2029)
6.2 North America Direct Agglutination Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Direct Agglutination Test Market Size by Country (2018-2023)
6.4 North America Direct Agglutination Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Direct Agglutination Test Market Size (2018-2029)
7.2 Europe Direct Agglutination Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Direct Agglutination Test Market Size by Country (2018-2023)
7.4 Europe Direct Agglutination Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Direct Agglutination Test Market Size (2018-2029)
8.2 Asia-Pacific Direct Agglutination Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Direct Agglutination Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Direct Agglutination Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Direct Agglutination Test Market Size (2018-2029)
9.2 Latin America Direct Agglutination Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Direct Agglutination Test Market Size by Country (2018-2023)
9.4 Latin America Direct Agglutination Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Direct Agglutination Test Market Size (2018-2029)
10.2 Middle East & Africa Direct Agglutination Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Direct Agglutination Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Direct Agglutination Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Atlas Medical GmbH
11.1.1 Atlas Medical GmbH Company Detail
11.1.2 Atlas Medical GmbH Business Overview
11.1.3 Atlas Medical GmbH Direct Agglutination Test Introduction
11.1.4 Atlas Medical GmbH Revenue in Direct Agglutination Test Business (2018-2023)
11.1.5 Atlas Medical GmbH Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Direct Agglutination Test Introduction
11.2.4 Thermo Fisher Scientific Revenue in Direct Agglutination Test Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Direct Agglutination Test Introduction
11.3.4 Bio-Rad Revenue in Direct Agglutination Test Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 HiMedia
11.4.1 HiMedia Company Detail
11.4.2 HiMedia Business Overview
11.4.3 HiMedia Direct Agglutination Test Introduction
11.4.4 HiMedia Revenue in Direct Agglutination Test Business (2018-2023)
11.4.5 HiMedia Recent Development
11.5 Pro Lab
11.5.1 Pro Lab Company Detail
11.5.2 Pro Lab Business Overview
11.5.3 Pro Lab Direct Agglutination Test Introduction
11.5.4 Pro Lab Revenue in Direct Agglutination Test Business (2018-2023)
11.5.5 Pro Lab Recent Development
11.6 Arlington Scientific
11.6.1 Arlington Scientific Company Detail
11.6.2 Arlington Scientific Business Overview
11.6.3 Arlington Scientific Direct Agglutination Test Introduction
11.6.4 Arlington Scientific Revenue in Direct Agglutination Test Business (2018-2023)
11.6.5 Arlington Scientific Recent Development
11.7 Hardy Diagnostics
11.7.1 Hardy Diagnostics Company Detail
11.7.2 Hardy Diagnostics Business Overview
11.7.3 Hardy Diagnostics Direct Agglutination Test Introduction
11.7.4 Hardy Diagnostics Revenue in Direct Agglutination Test Business (2018-2023)
11.7.5 Hardy Diagnostics Recent Development
11.8 Liofilchem S.r.l
11.8.1 Liofilchem S.r.l Company Detail
11.8.2 Liofilchem S.r.l Business Overview
11.8.3 Liofilchem S.r.l Direct Agglutination Test Introduction
11.8.4 Liofilchem S.r.l Revenue in Direct Agglutination Test Business (2018-2023)
11.8.5 Liofilchem S.r.l Recent Development
11.9 Biotec
11.9.1 Biotec Company Detail
11.9.2 Biotec Business Overview
11.9.3 Biotec Direct Agglutination Test Introduction
11.9.4 Biotec Revenue in Direct Agglutination Test Business (2018-2023)
11.9.5 Biotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
